139 related articles for article (PubMed ID: 25200599)
1. Exendin-4 improves cardiac function in mice overexpressing monocyte chemoattractant protein-1 in cardiomyocytes.
Younce CW; Niu J; Ayala J; Burmeister MA; Smith LH; Kolattukudy P; Ayala JE
J Mol Cell Cardiol; 2014 Nov; 76():172-6. PubMed ID: 25200599
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a.
Younce CW; Burmeister MA; Ayala JE
Am J Physiol Cell Physiol; 2013 Mar; 304(6):C508-18. PubMed ID: 23302777
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium.
DeNicola M; Du J; Wang Z; Yano N; Zhang L; Wang Y; Qin G; Zhuang S; Zhao TC
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E630-43. PubMed ID: 25117407
[TBL] [Abstract][Full Text] [Related]
5. Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.
Bao W; Holt LJ; Prince RD; Jones GX; Aravindhan K; Szapacs M; Barbour AM; Jolivette LJ; Lepore JJ; Willette RN; DeAngelis E; Jucker BM
Cardiovasc Diabetol; 2013 Oct; 12():148. PubMed ID: 24125539
[TBL] [Abstract][Full Text] [Related]
6. Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts.
Du J; Zhang L; Wang Z; Yano N; Zhao YT; Wei L; Dubielecka-Szczerba P; Liu PY; Zhuang S; Qin G; Zhao TC
Am J Physiol Cell Physiol; 2016 Feb; 310(4):C270-83. PubMed ID: 26739490
[TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP-mediated pleiotropic effects of glucagon-like peptide-1 receptor activation. Focus on "Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a".
Ye Y; Birnbaum Y
Am J Physiol Cell Physiol; 2013 Mar; 304(6):C505-7. PubMed ID: 23364263
[No Abstract] [Full Text] [Related]
8. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
9. Peptides Are Cardioprotective Drugs of the Future: The Receptor and Signaling Mechanisms of the Cardioprotective Effect of Glucagon-like Peptide-1 Receptor Agonists.
Boshchenko AA; Maslov LN; Mukhomedzyanov AV; Zhuravleva OA; Slidnevskaya AS; Naryzhnaya NV; Zinovieva AS; Ilinykh PA
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732142
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies.
Wohlfart P; Linz W; Hübschle T; Linz D; Huber J; Hess S; Crowther D; Werner U; Ruetten H
J Transl Med; 2013 Mar; 11():84. PubMed ID: 23537041
[TBL] [Abstract][Full Text] [Related]
11. The glucagon-like peptide-1 receptor agonist Exendin 4 has a protective role in ischemic injury of lean and steatotic liver by inhibiting cell death and stimulating lipolysis.
Gupta NA; Kolachala VL; Jiang R; Abramowsky C; Romero R; Fifadara N; Anania F; Knechtle S; Kirk A
Am J Pathol; 2012 Nov; 181(5):1693-701. PubMed ID: 22960075
[TBL] [Abstract][Full Text] [Related]
12. GLP1 protects cardiomyocytes from palmitate-induced apoptosis via Akt/GSK3b/b-catenin pathway.
Ying Y; Zhu H; Liang Z; Ma X; Li S
J Mol Endocrinol; 2015 Dec; 55(3):245-62. PubMed ID: 26386043
[TBL] [Abstract][Full Text] [Related]
13. Exendin-4 attenuates endoplasmic reticulum stress through a SIRT1-dependent mechanism.
Lee J; Hong SW; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Lee WY
Cell Stress Chaperones; 2014 Sep; 19(5):649-56. PubMed ID: 24446069
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy.
Niu J; Azfer A; Rogers LM; Wang X; Kolattukudy PE
Cardiovasc Res; 2007 Feb; 73(3):549-59. PubMed ID: 17207782
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 receptor agonist protects against hyperglycemia-induced cardiocytes injury by inhibiting high mobility group box 1 expression.
Cai Y; Hu X; Yi B; Zhang T; Wen Z
Mol Biol Rep; 2012 Dec; 39(12):10705-11. PubMed ID: 23053967
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB.
Cunha DA; Ladrière L; Ortis F; Igoillo-Esteve M; Gurzov EN; Lupi R; Marchetti P; Eizirik DL; Cnop M
Diabetes; 2009 Dec; 58(12):2851-62. PubMed ID: 19720788
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
[TBL] [Abstract][Full Text] [Related]
18. GLP-1 Receptor Activation Inhibits Palmitate-Induced Apoptosis via Ceramide in Human Cardiac Progenitor Cells.
Leonardini A; D'Oria R; Incalza MA; Caccioppoli C; Andrulli Buccheri V; Cignarelli A; Paparella D; Margari V; Natalicchio A; Perrini S; Giorgino F; Laviola L
J Clin Endocrinol Metab; 2017 Nov; 102(11):4136-4147. PubMed ID: 28938428
[TBL] [Abstract][Full Text] [Related]
19. MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species.
Morimoto H; Hirose M; Takahashi M; Kawaguchi M; Ise H; Kolattukudy PE; Yamada M; Ikeda U
Cardiovasc Res; 2008 Jun; 78(3):554-62. PubMed ID: 18267955
[TBL] [Abstract][Full Text] [Related]
20. The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.
Mann RJ; Nasr NE; Sinfield JK; Paci E; Donnelly D
Br J Pharmacol; 2010 Aug; 160(8):1973-84. PubMed ID: 20649595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
